NTAGI allows 1st dose as booster for those vaccinated with Sputnik: Report

Currently, there is no policy decision on providing a precaution dose to those inoculated with the Russian vaccine

Topics
Coronavirus | Coronavirus Vaccine

Press Trust of India  |  New Delhi 

vaccine, covid, corona, coronavirus
A healthcare worker administers a dose of Covid-19 preventive vaccine to an elderly person, in New Delhi, Saturday, April 23, 2022. (PTI Photo/Shahbaz Khan)

The first dose of Sputnik V vaccine can be administered as the precaution dose to all those vaccinated with the Russian COVID-19 jab, an NTAGI panel has recommended, official sources told PTI on Saturday.

The two doses of Sputnik V vaccine have separate compositions.

Currently, there is no policy decision on providing a precaution dose to those inoculated with the Russian vaccine.

The CoWIN portal does not show the option of precaution dose for Sputnik V.

Many Sputnik V recipients who had taken their second dose way back in July last year are unable to get the booster shot.

The two doses of Sputnik V are administered at a gap of 21-30 days.

The first dose of the vaccine contains a recombinant adenovirus type 26 (rAd26-S) and the second dose a recombinant adenovirus 5 (rAd5-S), an official explained.

"The NTAGI's Standing Technical Sub-Committee (STSC) which held its meeting on Friday discussed the issue and recommended that Sputnik Light which has the same component of Sputnik V's first dose will be given as the precaution dose," a official source told PTI.

The National Technical Advisory Group on Immunisation (NTAGI) is an advisory committee comprising multidisciplinary experts responsible for providing information and recommendations to government for making evidence-based decisions regarding vaccine and immunisation policy.

The Union Health Ministry is learnt to have received several representations over the precaution dose of Sputnik V.

According to sources, more than six lakh people have received the Russian vaccine.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus
First Published: Sat, April 30 2022. 19:46 IST
RECOMMENDED FOR YOU